rolling circle amplification

The firm is targeting customers in applied and clinical labs following commercial launch of its single-tube chemistries.

The partnership is part of Rarity's strategy to develop its molecular technology for widely adopted flow cytometry platforms.

The Swedish company is scaling up the production of targeted mutation assay kits and plans to release some of them for research use by the end of the year.